You are here: Industry Insights > Market News > Vaccine verdict due by early December: Anthony Fauci

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

TaYaCn Drying Pumpkin powder CT-C series hot air circulation oven

TaYaCn Drying Lysimachia christinae CT-C series hot air circulation oven

TaYaCn Drying cabbage CT-C series hot air circulation oven

TaYaCn Drying Shrimp skin CT-C series hot air circulation oven

TaYaCn Drying Stone heat treatment CT-C series hot air circulation oven

TaYaCn Drying Banana slices CT-C series hot air circulation oven

Vaccine verdict due by early December: Anthony Fauci

expresspharmaOctober 26, 2020

Tag: Anthony Fauci , COVID-19 Vaccine , vaccination

Favorites

US infectious disease expert Anthony Fauci said it would be clear whether a COVID-19 vaccine was safe and effective by early December, but that more widespread vaccination would not be likely until later in 2021.

“We will know whether a vaccine is safe and effective by the end of November, the beginning of December,” Fauci told the BBC.

He said, “When you talk about vaccinating a substantial proportion of the population, so that you can have a significant impact on the dynamics of the outbreak, that very likely will not be until the second or third quarter of the year.”

Previous:CaDi introduces Lycofertilic? - high potency, targeted supplements with algae DHA Omega-3 to provide anti-ageing support for the ovarian reserve and to prepare for egg retrieval and IVF

Next:Mexico may not follow FDA and approve remdesivir for COVID-19

Alzheimer’s Disease: Charting the Course from Plaques to Promise

Muhammad Farhan KhalidMay 28, 2025

New Tools，New Hope，New Frontier

InnoCare Announces First Patient Dosed in the Phase II/IIII Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Vitiligo in China

PharmaSourcesMay 16, 2025

The Phase 3 Clinical Trial of Disitamab Vedotin as a First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic ?Urothelial Carcinoma Reached its Primary Endpoints of PFS and OS

PR NewswireMay 12, 2025

Vaccine verdict due by early December: Anthony Fauci | Pharmasources.com

Illuccix China Phase 3 Study Completes Enrolment

PR NewswireMay 13, 2025

Telix Pharmaceuticals Limited announces that the pivotal Phase 3 registration study of TLX591-CDx for prostate cancer imaging in Chinese patients has completed patient enrolment.